IT-Fic 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent indicated for the treatment of various fungal infections. Itraconazole exerts its antifungal effect by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for ergosterol synthesis, a critical component of fungal cell membranes. This inhibition results in increased membrane permeability and ultimately fungal cell death. IT-Fic 100 Capsule is commonly prescribed for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. The medication demonstrates efficacy against a wide range of pathogenic fungi, including Candida species, Aspergillus species, and dermatophytes. It is administered orally, with absorption enhanced when taken with food. Dosage and duration depend on the type and severity of infection and should be determined by a healthcare professional. Caution is advised in patients with hepatic impairment or congestive heart failure, and potential drug interactions should be carefully evaluated due to itraconazole’s effect on cytochrome P450 enzymes. Common adverse effects include gastrointestinal disturbances, headache, and rash. IT-Fic 100 Capsule should be used under medical supervision, with monitoring for therapeutic response and adverse reactions to ensure optimal outcomes.